John L. Stock

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial

P. D. Delmas, Harry K. Genant, Gerald Crans et al. · Bone · 2003 · 541 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +11

Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy

Somnath Sarkar, Bruce Mitlak, Mayme Wong et al. · Journal of Bone and Mineral Research · 2002 · 450 citations · Full text

Medicine, Endocrinology, Orthopedic Surgery +17

Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling

Charles H. Chesnut, Michael R. McClung, Kristine E. Ensrud et al. · The American Journal of Medicine · 1995 · 367 citations

Medicine, Endocrinology, Bone Metabolism +14

Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study

Ethel S. Siris, Steven T. Harris, Richard Eastell et al. · Journal of Bone and Mineral Research · 2005 · 242 citations

Medicine, Oncology, Pharmacotherapy +17

Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism

Maurice F. Attie, J R Gill, John L. Stock et al. · Journal of Clinical Investigation · 1983 · 196 citations · Full text

Medicine, Endocrinology, Nephrology +17